Radiation leukaemogenesis: is virus really necessary? by Loutit, J. F. & Ash, P. J.
Br. J. Cancer (1978) 38, 24
RADIATION LEUKAEMOGENESIS: IS VIRUS REALLY NECESSARY?
J. F. LOUTIT (VISITOR) AND P. J. N. D. ASH
Fronb the M.R.C. Radiobiology Unitt, Harwell, Dideot, OXI1 ORD
Receive(d 16 Februaiy 1978 Accepted 31 March 1978
Summary.-Generalized lymphosarcomatosis (leukaemia) ofnon-thymic typeoccurs
in mice bearing 90Sr or 239Pu or 226Ra. Tumours passaged from such mice have been
tested for tumour-associated transplantation antigens that could provoke aprotective
immunity which would be expected if such antigens were determined by virus
activated by the irradiation. Sub-threshold doses of living syngeneic tumour, large
doses of living allogeneic tumour and large doses of killed syngeneic tumour were
without protective effect. This suggests that viruses observed electron micrographic-
ally in such tumours are passengers and not causative.
THERE is little information on tumour
immunology of radiation-induced lym-
phomas compared with other murine
lymphomas.
It is now recognized that many tumours
have antigens (tumour-associated trans-
plantation antigens, TATA) in addition to
those inherited in the corresponding nor-
mal cell. Chemically induced tumoursoften
have "strong" TATA which are individual
to each tumour. Naturally occurring tu-
mours, on the other hand, usually have
very weak or undemonstrable TATA.
Tumours induced in the laboratory by
preparations containing oncogenic virus
have TATA of variable strength, though
these are not individualistic but common
to the tumours induced and determined
by the particular virus. However, some
viruses are reported toproducelittleTATA
(Jones and Moore, 1973) and no report has
been traced of significant TATA in the
prototype viral lymphoma (Gross) ofAKR
mice with vertical inheritance of virus.
Nevertheless, Klein et al. (1962) demon-
strated tumour antigen associated with
GCross virus horizontally transmitted to
recipient (C3H) mice as allografts of Gross
lymphosarcomas from mice of another
genotype, or as isografts of sub-threshold
doses of cells from the same syngeneic
lymphosarcoma.
Radiation-induced lymphoma in labora-
tory mice is most frequently reported,
after total body X-irradiation, as a thy-
moma with haematogenous spread (leu-
kaemia) to other tissues, especially lym-
phoid. Lieberman and Kaplan (1959) and
Kaplan (1977) attribute the disease to
"activation" of a latent oncogenic virus.
However, not all generalized lymphosar-
comas following total body X-irradiation
arise in the thymus in this way; some,
notably those occurring late, are of a
generalized non-thymic type (Mole, 1958).
Similar generalized non-thymic lympho-
sarcomas have been seen in mice injected
with the bone-seeking radionucleides 90Sr,
239Pu and 226Ra at Harwell, involving the
strains CBA/H, C3H/H and their hybrids
(Loutit and Carr, 1978). Whenever these
primary tumours have been examined
electron micrographically, virus has been
visible (e.g. Loutit and Lloyd, 1977).
These lymphosarcomas have been kept
in passage in unirradiated compatible mice
and used in the manner of Klein et al.
(1962) as a source of tumour-associated
antigen (virally specific) to see whether
repeated administration of such antigen
led to progressive resistance to the tumour.
It was argued that, iftheradiation-induced
lymphosarcoma were dependent on the
activation of an endogenous virus, itVIRUS AND RADIATION LEUKAEMIA
should behave in similar fashion to Gross
agent in the experiments of Klein et al.
In the event, no increased resistance
could be established, even though virus
was demonstrably present electron micro-
graphically in all the passaged tumours
extant at the conclusion ofthe experiment.
METHODS AND MATERIALS
Tumours
Lines were maintained by serial passage of
affected tissue, usually lymph nodes, sus-
pended by Tyrode's solution after coarse
homogenization. For routine passage the
suspension (uncounted) was injected under
loose skin in the groin.
Titration
Single-cell suspensions in Tyrode's solution
were counted in a Biirker haemocytometer
after dilution with 2% acetic acid. From the
original suspension, dilutions were then made
to give 10-fold dilutions with 106, 105, 104 etc.
cells per 0-1 ml Tyrode's solution, dilutions
being injected into groups of 3-10 mice s.c. in
the groin. The results were scored as deaths
from progressive lymphosarcomatosis within
2 months. In some cases additional titrations
were made of the dose to kill after i.p.
administration.
Treatments
Small doses ofliving cells.-Most ofthe mice
that survived the sub-threshold dose of living
cells in titration as previously untreated mice
became "treated" mice in a later series, and
were re-challenged with the same tumour at
a higher dose level but at a different subcuta-
neous site. If they still survived, they were
rechallenged at a yet higher dose and a third
site, and so on. A few mice were not serially
treated in this way, to ensure that the 2-
months period excluded late responders.
Large doses of living cells.-There could be
few survivors above the median level of a
histocompatible tumour (usually 103-104 cells
when given s.c.). Therefore, to increase the
dose of putative viral tumour-associated-
antigen it was necessary to give histoincom-
patible cells (cf. Klein et al., 1962). Mice ofthe
parental strain, CBA, were thus treated with
3 weekly injections of lymphosarcoma from
F1 hybrids between CBA and C3H, cells from
tumours arising in both (C3H xCBA)F1 and
(CBA xC3H)F1 hosts being used. The number
of cells given were 105, 106 and 107 in series
at 3 different subcutaneous sites: nopersistent
local tumour resulted.
Large doses of inactivated cells.-Larger
doses of putative viral tumour-associated
antigen could also be obtained by abolishing
the reproductive capacity of the living lym-
phosarcoma cells by X-irradiation in vitro
with 104 rad. Local tumour or infiltrated
lymph node, about 100 mg, was removed
aseptically, irradiated in a sterile Petri dish
and then made into suspension in Tyrode's
solution. Each syngeneic recipient received
s.c. about 5 mg of reproductively sterilized
tumour. Three equal doses were given at
weekly intervals.
Recording
Test mice, treated and untreated, were
examined daily until natural or euthanasic
death, and then subjected to necropsy.
Virus particles in passaged mouse lymphomas
Two tissue samples were taken from each
mouse, one from the tumour at the injection
site and one from the axillary lymph node.
Each tissue sample was cut into 1 mm3 pieces
and fixed in 2.5% glutaraldehyde in 0dIM
sodium cacodylate for 1-2 h. The pieces were
embedded individually in Araldite. Three
pieces from each sample were sectioned for
light microscopy and stained with Azure II.
If the light-microscope sections showed well-
fixed cells, ultra-thin sections of the same
block were cut, mounted on parlodion-coated
grids and stained with lead citrate. The grids
examined with an A.E.I. EM6 electron
microscope.
RESULTS
Small doses of living cells
The results for the most extensively in-
vestigated tumour, Sr42/3, are given in
Table I, in similar format to the results of
Klein et al. (1962) for Gross virus leukae-
mia. In contrast to their results, in which
for each column of the treated animals the
deaths were significantly less than in cor-
responding untreated animals, there is no
significant difference except after ad-
ministration of 103 cells. Here, in striking
contrast to the findings of Klein et al., the
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TABLE I. Deaths from generalized lymphosarcoma, Sr42/3,
CBA mice
in untreated and treated
Untreated mice
10 10'2 103 104
S.c. inijection
Passage No. 58
66
67
71
73
76
80
81
85
86
87
92
93
99
Stum
x2 with Yates'
correction
I.P. injection
Passage No. 86
92
99
SuIm
1/9 3/1(
0/8 2/3
1/3
0/4 3/4
2/3 1/4
0/7 1/7
0/6
3/5
(/5 (/5 1/5
Cell (iose in
Treated mice
105 102 103 104 105
6/6
1/3
2/3
4/8
5/7
7/8
3/5 3/5
0/5 2/2
8/8
5/9
3/4
0/1
5/5
2/2
6/6
5/5
:3/3
0/4 2/4
1/14 5/37 12/41 30/42 11/11
5/5
4/4
1/1
7/8
4/6
5/7
6/7
6/7
3/5 3/4
1/2
3/10 31/41 42/51
0573 1584 1 01
0 45 0 000069 0 32
0/3
:3/5
3/8
3/3 :l/:l
4/5 1/1
3/4
10/12 4/4 3/3 4/4
3/3 4/4
treated animals were significantly more
susceptible. The numbers are supported by
findings at necropsy. These animals tended
to die early with an exudative syndrome
with peritoneal haemorrhage rather than
local formative metastasizing tumours.
The small body of data for similar animals
untreated or pretreated with tumour cells
and challenged by i.p. injections gives no
indication that the route ofadministration
is a factorinthelackofprotective response.
Table II lists the details of 5 other
generalized lymphosarcomas (2 of the
CBA strain, 3 of C3H) given to previously
untreated or treated mice of the appropri-
ate strain. In none of the 5 groups is there
an indication that prior exposure to sub-
lethal doses of living cells of the tumour
induces resistance.
Large doses of living cells
Table III lists details of the other
approach with living cells. Mice ofparental
strain (CBA) were exposed to substantial
numbers of living lymphosarcoma cells
from reciprocal hybrids of C3H and CBA.
These tumours having been rejected
through histoincompatibility, the mice
were challenged with CBA lymphosarcoma
cells. Once again there was no observable
protection.
Large doses of inactivated cells
Table IV lists details to show that CBA
and C3H mice pretreated with 3 doses of
syngeneic tumour, the reproductive po-
tential of which had been inactivated by
104 rad of X-rays, were no more resistant
to living cells of the same lymphosarcoma
than untreated mice.
Ultrastructure of tumnour samples
The samples from the injection site and
axillary lymph node consist almost entire-
ly of leukaemic cells (Fig. 1). The cells
usually show a high nuclear: cytoplasmic
ratio. The plasma membrane is irregular,
showing some finger-like projections. The
106
2/2
2/2
5/6
4/4
4/4
1/1
1/1
19/20
0 0951
1/1
1/1
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TABLE II.-Deaths from generalized lymphosarcoma in untreated and treated mice
Cell dose in
Passage
Strain Tumour Nuimber
CBA PB Sr 11/4 (30)
(37)
(38)
Sulm
P*
Pu 3/4
Sum
P*
C3H Ra 62/2
Sum
P*
Unitreatedl mice
102 103 104 10;
0/7 1/7 5/6
:3/4 4/4 4/4
3/4 4/4 4/4
0/7 7/15 13/14 8/8
(37) 0/8 4/8 7/8 5/5
(40) 2/5 4/5
(45) 0/6 6/6 4/4
2/19 14/19 11/12 5/5
(27)
(31)
(36)
(41)
(47)
(56)
2/7 1/7 4/5
0/3 1/31
0/6 3/7
0/4 0/5 0/4
1/4 4/4 4/4
0/7 4/25 8/22 8/9
Treated mice
103 104 105 106
7/7 6/6
3/6 5/5
10/13 11/l1
0:33
8/8 4/4 1/1
1/3 1/1
9/1 1 5/5 1/1
1 1
2/5 5/6 1/1 -
0/5 2/3 1/1
1/11 4/5
0/4 0/5 5/15 1/1
4/4 5/5 9/9
2/14 12/29 16/27 10/10
1 0 78 0-11
(25) 1/8 4/8 5/5
(28) 1/4 1/4 2/3
(30)
2/12 5/12 7/8
0/6 3/5 2/2
0/5 0/5 4/5
0/2 0/6 0/4
0/4 1/4 3/4
0/1:3 3/20 7/15 3/4
2/8 4/4
0/3 8/8 1/1
2/11 12/12 1/1
0.37 0 4
6/12 4/4
2/4 8/11 1/1
5/9 7/7
8/16 17/24 8/8
0(034 0 18 0.33
* By Fish-er's exact test.
TABLE III.-Deathsfrom generalized lymphosarcoma in CBA mice untreated andpretreated
with substantial doses of living lymphosarcoma
Cell (lose in
Pre-treatment Test
with tumour tumour
(host) (host)
Ra 56/1 Sr 42/3 (60)
(CBA x C3H)F1 (CBA)
,, 1PB Sr 11/4 (30
(CBA)
Untreated mice
A
102 103 104
3/10 6/6
0/7 1/7 5/6
Treated mice
102 103 104 105
2/9 7/7 7/7
1/9 4/7 5/5
Ra 51/1 Sr 42/3
(C3H x CBA)F1 (CBA)
(71) 1/3 1/' (/9) 2/8 6/6
cytoplasm often contains one or more lipid and fibrin are frequently seen amongst the
droplets. The nuclei are ofirregular shape, tumour cells.
with prominent nucleoli and some con- The cytoplasm of the leukaemic cells is
centration of chromatin at the nuclear loaded with polyribosomes (Fig. 2 and 3).
membrane. Macrophages, red blood cells Endoplasmic reticulum is poorly devel-
Sr 54/4
Sum
P,*
Sr 52/1
Slum
p
(65)
(71)
(73)
(83)J. F. LOUTIT AND P. J. N. D. ASH
TABLE IV.-Deaths from generalized lymphosarcoma in mice untreated and pretreated
with synqeneic tumour exposed to 104 rad X-rays
Cell dose in
I -I
Tumour strain
Sr 50/5 C3H
Sr 52/1 C3H
Sr 42/3 CBA
Passage
nuTnber
(48)
(65)
(73)
Untreated mice
-
102 103 104
0/5 0/5 5/5
0/6 3/5 2/2
0/4 3/4
Treated mice
I -.
102 103 104
0/6 4/8 6/6
0/6 4/6 6/6
7/8 7/8
or1.* 1.o.uecuion irolm an injecTion sne. Lne sample consistsOI ciosely pacKec ieuxaemic cels ot irregu-
lar shape. The leukaemic cells usually show a high nuclear:cytoplasmic ratio. The cytoplasm is
loaded with ribosomes. Lipid droplets are common. Clumps offibrin and red blood cells can be seen
amongst tumour cells. x 8,000.
oped, consisting ofshort flat cisternae (Fig.
2). Mitochondria are fairly abundant.
Virus particles in tumour samples
The relative abundance ofvirusparticles
is listed in Table V. As so few sections from
each block were examined, the observed
abundance of virus in each sample may
not be the true one. The important point
is that virusparticleswerefoundinsamples
from all 7 animals. The particles showed
the characteristic morphology described
by other workers for virus found in murine
28
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TABLE V.-Relative abundance of virus
particles in passaged leukaemia samples
Relative abundance of virus
--.
A
Axillary
Leukaemia line lymphnode Injection site
Sr 52/1-109 ++* None
Sr 42/3-117 n.e. +
Ra 62/2-71 + + + + + +
Ra 56/1-69 + +
Ra 51/1-50 n.e. +
Sr 54/4-47 + + + + + +
Pu 3/4-64 Very scarce Very scarce
* The number of + signs indicates roughly the
abundance ofvirus, + + + meaning very abundant.
n.e. Not examined.
leukaemias (e.g. Dalton et al., 1961;
Brandes, et at., 1966; Dalton, 1972a).
Intracellular particles are often found
within tubular structures which wrap
themselves around the virus (Fig. 2) and
may be derived from smooth endoplasmic
reticulum. Virus particles are also seen
within cisternae of rough endoplasmic
reticulum (Fig. 3). Suchparticles areround
and ,80-90 nm in diameter. There is a
pale nucleoid enclosed by 2 concentric
electron-dense rings. The formation of a
virus particle by budding into a cisterna
of the endoplasmic reticulum is shown in
Fig. 2 (inset). The intracytoplasmic loca-
tion, the size and morphology of the virus
particles, place them in the A group of
Bernhard and Granboulan (1962). Dalton
(1972b) classified such particles as Intra-
cisternal Type A.
Extracellular virus particles are also
seen, but they are much scarcer thanintra-
cellular virus. The extracellular virus
FIG. 2.-Portion of the cytoplasm of a leukaemic cell. Polyribosomes are abundant. Virus particles
(arrowed) are visible within smooth-walled tubular structures which may be derived from smooth
endoplasmic reticulum. The virus particles consist of a pale nucleoid surrounded by 2 concentric
electron-dense layers. x 47,000.
Inset. Granular endoplasmic reticulum consists ofshort flattened cisternae. Note the virusparticle
budding into the cisterna. x 40,000.J. F. LOUTIT AND P. J. N. D. ASH
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FiG. 3.-A virus particle, about 100 nm in diameter, has almost completely budded from the plasma
membrane of a leukaemic cell. Lipid droplets can be seen in the cytoplasm. x 40,000.
particle is made up of an inner core of the
same structure as the A particle, sur-
rounded by a membrane (Fig. 3). The total
diameter of the extracellular particle is
...90-100 nm. The outer membrane is be-
lieved to be derived from the plasma mem-
brane of the cell during budding (Dalton,
1972a). A late stage of budding is seen in
Fig. 3, where the virus is almost complete-
ly separated from the cell. The extracellu-
lar virus seen in the passaged mouse
leukaemias resembles those particles be-
lieved by Dalton to be the intermediate
stage between Type A and mature Extra-
cellular Type C. No convincing mature C-
type particles as described by Dalton
(1972a) were seen in the present study, but
this may be due to the differences in the
method of fixation. Dalton used chrome
osmium asafixative, whereasinthepresent
study glutaraldehyde followed by osmium
was used.
Intracellular or A-type virus was found
in samples from all 7 animals. Budding and
intact particles were found in samples from
all animals, even in those from Pu 3/4-64
where virus was very scarce. Extracellular
virus was found in 6/7 animals, being
apparently absent in Pu 3/4-64. Particles
budding from the plasma membrane were
rare, being found only in Sr 42/3-117 and
Sr 52/1-109.
DISCUSSION
The experiments were designed to test a
hypothesis that radiation-induced murine
leukaemias (general lymphosarcomatoses)
are due to activation of a latent oncogenic
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virus. From C57BL/Ka X-irradiated mice
a virus had been isolated, and nominated
Rad LV, which might lead the unwary
to suppose that a specific virus (or acti-
vated precursor virus) were responsible
for all murine radiation-induced leukae-
mias, as, when the association ofvirus with
the spontaneous leukaemia of AKR was
first accepted, it was predicted that all
murine lymphosarcomas might be due to
Gross virus.
However, the leukaemias under dis-
cussion were not the more commonly re-
ported thymic lymphosarcomas (T-cell
leukaemias; Haran Ghera and Peled, 1973)
but generalized leukaemias ofnull-celltype
(Loutit and Carr, 1978; Mehrishi and
Loutit, 1977) induced presumably in
lymphocyte precursors in marrow from
radionucleides in adjacent bone, or spon-
taneous, though the strains of mice used
have a low rate ofany form ofspontaneous
lymphosarcoma. Secondly, the prediction
that the leukaemia virus might be unique
has been demonstrably untrue. Murine
leukaemia viruses have proliferated to an
alarming extent, many (e.g. Friend virus)
being engineered in the laboratory from
widely disparate malignant cells unrelated
to the natural disease but most valuable
in elucidating the genetics and immu-
nology of oncogenic viruses (Old and
Stockert, 1977).
Had there been a single virus responsible
for radiation-induced leukaemia and, like
the Friend-Maloney-Rauscher group of
engineered leukaemias, productive of
TATA, the current investigation should
have been able to show the development
of some protective immunity not only
within individual leukaemias (Tables I,
HI and IV), but between leukaemias (Table
III).
In none of the 3 variants of the treat-
ment (small sub-threshold doses of living
compatible leukaemic cells, or substantial
and repeated doses of allied but incom-
patible leukaemic cells, or larger repeated
doses of sterilized compatible cells) was
there a suggestion that protective im-
munity, even of a weak form, had been
elicited (Tables I-IV). This is not to be
taken that some immunological activity
had not been invoked. Tables I and II
indicate that 2 of the leukaemias, per-
haps by virtue of an associated antigen,
had produced on the contrary a significant
degree of sensitization and accentuated
response (cf. Prehn, 1975; Hewitt et al.,
1976).
If a single virus had been involved, its
TATA was not productive of protective
immunity. If multiple viruses were re-
sponsible, none of them was productive.
It has been demonstrated after the com-
pletion of the immunological studies, that
7/9 tumours under investigation contained
electron-micrographically visible virus, in-
tracisternal A or extracellular C or both,
even though the tumours hadbeenthrough
many passages. The viruses were actively
budding, but no attempt was made to
categorize them immunochemically.
The question at issue is were these
viruses oncogenic and causing the leu-
kaemias or incidental passengers?
It is now accepted that all mice, labora-
tory and feral, contain murine leukaemia
viral peptides built into the genome, and
serum antibodies thereto (Nowinski, 1975).
Vertically inherited viral antigens may
exert some measure of immunological
tolerance which, if they were oncogenic,
might cause the absence of a response to
TATA (Klein, 1975). However, there is
now evidence that the inherited virus or
proviruses may per se be relatively harm-
less and that a variant may be responsible
for oncogenicity (Nowinski et al., 1977).
Hartley et al. (1977) attribute the onco-
genicity to recombination amongst the
resident virus. If similar recombination
obtained in the radiation-induced lym-
phoma, this new virus should be, like a
horizontally transmitted virus, immuno-
genic and not subject to inducing toler-
ance. The present series of experiments
should thus be a fair analogue to that of
Klein et al. (1962).
Our failure to find evidence of a virus-
associated TATA would be explicable as a
rare chance event, if radiation-induced32 J. F. LOUTIT AND P. J. N. D. ASH
lymphoma virus were unique; but, if one
accepts the compelling evidence of multi-
plicity ofleukaemia viruses, failure to find
protective immunity in tests of 7 syn-
geneic lymphomas becomes persuasive.
Two recent reviews by Todaro (1978) and
Klein and Klein (1977) both stress the
generality of strong TATA for virally
transformed cells, and thus the role of
immunological surveillance in the control
of such neoplasms. Klein and Klein made
a strong case for the commonly investi-
gated AKR leukaemia having been en-
gineered by selection in the laboratory,
and thus exceptional. Todaro argues that
neoplastic transformation may facilitate
the emergence of virus to alert the immu-
nological mechanism. Thus a sequence of
7 leukaemias without evident TATA sug-
gests to us origins other than viral, the
observed viruses resulting from non-
specific phanerosis.
Pursuit ofthe virus theory ofleukaemo-
genesis must have 2 objects. First, there
is the basic study of viruses in neoplasms,
causative or incidental, a testing exercise
in microbiology in which virologists have
made tremendous progress in the last few
years. Second, there is the applied appeal
of the possibility of immunoprophylaxis.
As far as radiation-induced, leukaemia is
concerned, there is yet no practical vaccine
for the thymic type, and the experiments
reported here give no encouragement for
the non-thymic type.
The virologist may explain the carcino-
inductive event as distortion ofthe normal
sequences of nucleotides in nuclear DNA
by the insertion of virally derived nucleo-
tides, followed by loss of normal genetic
interaction and control. This places no
constraint on the radiobiologist to explain
radiation-induced cancer and leukaemia
through the mediation ofvirus. Ionization
in DNA induces damage which may repair
completely, or misrepair leading to entire-
ly similar distortion of the sequences of
nucleotides. Indeed it is now reported
(Lloyd et al., 1978) that os particles can
cause malignant transformation of cells in
culture, the transformed cells differing
from virally transformed analogues. To-
daro (loc. cit.) goes further, to speculate
that acquisition ofvirogenes in the genome
may be a device to,introduceadvantageous
genetic variation from outside into a
closed breeding species, some oncogeneity
being an occasional penalty. Radiation
induces genetic variation (mutation) with-
in the closed system and the penalty is
abundant neoplasia.
We are greatly indebted for comment on an earlier
draft to Drs A. Decleve, M. P. Finkel, H. Hewitt, G.
Klein, L. G. Lajtha, I. Major, J. Mehrishi, R. H.
Mole, M. Moore and C. H. G. Price; to Mr D. Pap-
worth for statistics and Mrs Ann Bates for the type-
script.
One of us (J.F.L.) is working with a project grant
from the Medical Research Council.
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